Marcia T Ruiz

Malignancy-Associated Hypercalcemia Experimental Skeletal Metastases , and Prostate Secretory Protein Can Reduce Tumor Growth , A Synthetic 15-mer Peptide ( PCK 3145 ) Derived from Updated

S. Rabbani, N. Shukeir, Gaoping Chen, 2004 .

A Synthetic 15-mer Peptide (PCK3145) Derived from Prostate Secretory Protein Can Reduce Tumor Growth, Experimental Skeletal Metastases, and Malignancy-Associated Hypercalcemia

S. Rabbani, N. Shukeir, Gaoping Chen, 2004, Cancer Research.

Identification, purification and characterization of a novel human blood protein with binding affinity for prostate secretory protein of 94 amino acids.

J. R. Reeves, J. Wiśniewski, S. Garde, 2005, The Biochemical journal.

A prostate secretory protein94‐derived synthetic peptide PCK3145 inhibits VEGF signalling in endothelial cells: Implication in tumor angiogenesis

S. Lamy, B. Annabi, S. Rabbani, 2006, International journal of cancer.

A post hoc analysis of dalteparin versus oral anticoagulant (VKA) therapy for the prevention of recurrent venous thromboembolism (rVTE) in patients with cancer and renal impairment

F. Jen, S. Woodruff, P. Abreu, 2016, Journal of Thrombosis and Thrombolysis.